These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 8522262)

  • 21. Lymph node metastasis in stage I ovarian carcinoma.
    Lang JH
    Chin Med J (Engl); 1994 Sep; 107(9):643-7. PubMed ID: 7805453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Micropapillary pattern in serous borderline ovarian tumors: does it matter?
    Park JY; Kim DY; Kim JH; Kim YM; Kim KR; Kim YT; Nam JH
    Gynecol Oncol; 2011 Dec; 123(3):511-6. PubMed ID: 21917305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does systematic lymphadenectomy have a benefit on survival of suboptimally debulked patients with stage III ovarian carcinoma? A DEGOG* Study.
    Saygili U; Guclu S; Uslu T; Erten O; Ture S; Demir N
    J Surg Oncol; 2002 Nov; 81(3):132-7. PubMed ID: 12407725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro fertilization following conservative management of stage 3 serous borderline tumor of the ovary.
    Hoffman JS; Laird L; Benadiva C; Dreiss R
    Gynecol Oncol; 1999 Sep; 74(3):515-8. PubMed ID: 10479523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of lymph node involvement in ovarian serous borderline tumors.
    Lesieur B; Kane A; Duvillard P; Gouy S; Pautier P; Lhommé C; Morice P; Uzan C
    Am J Obstet Gynecol; 2011 May; 204(5):438.e1-7. PubMed ID: 21349494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer.
    Negishi H; Takeda M; Fujimoto T; Todo Y; Ebina Y; Watari H; Yamamoto R; Minakami H; Sakuragi N
    Gynecol Oncol; 2004 Jul; 94(1):161-6. PubMed ID: 15262135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Borderline tumor of the lymph node associated with bilateral serous borderline tumor of the ovary: case report.
    Tulunay G; Baykal C; Cil A; Kahraman B; Ozer S; Cavuşoğlu D
    Eur J Gynaecol Oncol; 2004; 25(5):632-4. PubMed ID: 15493184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The place of lumo-aortic and pelvic lymph node dissection in the treatment of ovarian cancer].
    Salet-Lizée D; Alsary S
    J Chir (Paris); 2008 Dec; 145 Spec no. 4():12S45-12S49. PubMed ID: 19194358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful term pregnancy following conservative debulking surgery for a stage IIIA serous low-malignant-potential tumor of the ovary: a case report.
    Miller DM; Ehlen TG; Saleh EA
    Gynecol Oncol; 1997 Sep; 66(3):535-8. PubMed ID: 9299273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical staging of ovarian low malignant potential tumors.
    Rao GG; Skinner E; Gehrig PA; Duska LR; Coleman RL; Schorge JO
    Obstet Gynecol; 2004 Aug; 104(2):261-6. PubMed ID: 15291997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Serous papillary cancer of the peritoneum: a multicentric primary disease].
    Maassen V; Debus-Thiede G
    Zentralbl Gynakol; 1993; 115(8):347-54. PubMed ID: 8212940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0).
    Sakuragi N; Yamada H; Oikawa M; Okuyama K; Fujino T; Sagawa T; Fujimoto S
    Gynecol Oncol; 2000 Nov; 79(2):251-5. PubMed ID: 11063653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors.
    Lu KH; Bell DA; Welch WR; Berkowitz RS; Mok SC
    Cancer Res; 1998 Jun; 58(11):2328-30. PubMed ID: 9622067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Retroperitoneal lymph node metastasis in epithelial cancer of the ovary: a report of 58 cases].
    Xie R; Lin YZ; Chen GL
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):499-501. PubMed ID: 15555344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serous cystadenoma of the pancreas with invasive growth: benign or malignant?
    Abe H; Kubota K; Mori M; Miki K; Minagawa M; Noie T; Kimura W; Makuuchi M
    Am J Gastroenterol; 1998 Oct; 93(10):1963-6. PubMed ID: 9772066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benign müllerian inclusions in pelvic and paraaortic lymph nodes.
    Reich O; Tamussino K; Haas J; Winter R
    Gynecol Oncol; 2000 Aug; 78(2):242-4. PubMed ID: 10926810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution pattern and risk factors of pelvic and para-aortic lymph node metastasis in epithelial ovarian carcinoma.
    Tsumura N; Sakuragi N; Hareyama H; Satoh C; Oikawa M; Yamada H; Yamamoto R; Okuyama K; Fujino T; Sagawa T; Fujimoto S
    Int J Cancer; 1998 Oct; 79(5):526-30. PubMed ID: 9761124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pathology of and controversial aspects of ovarian borderline tumours.
    McCluggage WG
    Curr Opin Oncol; 2010 Sep; 22(5):462-72. PubMed ID: 20531187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnostic difficulties in serous "borderline" tumors of the ovary].
    Vereczkey I; Tóth E; Orosz Z
    Magy Onkol; 2009 Mar; 53(1):23-31. PubMed ID: 19318323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serous tumours of low malignant potential (serous borderline tumours): moving toward détente.
    Longacre TA; Kempson RL; Hendrickson MR
    Histopathology; 2005 Sep; 47(3):315-8. PubMed ID: 16115233
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.